19th Annual International Symposium on Ventricular Arrhythmias | Heart Rhythm Society

19th Annual International Symposium on Ventricular Arrhythmias

19th Annual International Symposium on Ventricular Arrhythmias

The 19th Annual International Symposium on Ventricular Arrhythmias is the premier conference for the latest insights on the pathophysiology and treatment of ventricular arrhythmias. It features live case demonstrations, expert lectures, interactive panel discussions, and debates. Attendees will gain real-time exposure to complex ablation techniques performed at renowned institutions like Mount Sinai and the University of Pennsylvania Hospital. This symposium is a must-attend for those seeking to enhance their knowledge of cutting-edge advancements in ventricular arrhythmia research and treatment.

PROGRAM DIRECTORS:
  • Vivek Reddy, MD
    Mount Sinai Hospital
    New York, NY
     
  • Srinivas Dukkipati, MD
    Mount Sinai Hospital
    New York, NY
     
  • Francis Marchlinski, MD
    University of Pennsylvania Health System
    Philadelphia, PA
     
  • David Callans, MD
    University of Pennsylvania Health System
    Philadelphia, PA
     
  • Andre d’Avila, MD, PhD
    Beth Israel Deaconess Medical Center,
    Boston, MA
LEARNING OBJECTIVES:
  • Discuss strategies to improve treatment outcomes in patients with ventricular arrhythmias and structural heart disease, including new techniques and technologies.
  • Discuss the current status and future role of device therapy in managing sudden cardiac death and heart failure.
  • Discuss the role of new techniques for VT substrate assessment, including functional scar imaging, intraprocedural MRI, and high-density mapping.
  • Perform risk stratification for sudden death and treatment, including VF ablation, in patients with VF due to various substrates and syndromes.
  • Identify the challenges related to the treatment of PVCs and idiopathic VT.
  • Describe the science critical to the understanding and treatment of ventricular arrhythmias, including:
    • The role of the autonomic nervous system in ventricular arrhythmogenesis.
    • The anatomic substrate for ventricular tachycardia (VT).
  • Describe the status of ongoing multicenter VT-related trials and discuss future directions and questions to be answered.
TARGET AUDIENCE:
  • Cardiologists
  • Clinicians
  • Electrophysiologists/EPs
  • Fellows/Trainees
  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Technicians
  • Scientists
  • Academic
  • Researcher

 

 

 

 

Date and Time October 11-12, 2024
6:45 am - 5:00 pm
Location

Brooklyn, New York United States of America

Topics
Ablation
Clinical EP
Device Therapy
Disorders
Sudden Cardiac Arrest
Ventricular Arrhythmias
Our Sponsors

Membership Reminder

RENEW MEMBERSHIP